Prez Trump warns reprieve for pharmaceuticals, major Indian export, to end ‘shortly’

Israeli researchers develop AI tool to decode cell responses to drugs

S. Korea seeks to boost animal medicine market to $2.7 billion by 2035

Celltrion targets $3.46 bn in sales this year on biosimilars

Celltrion launches autoimmune disease treatment in US

Indian pharma market to grow 8-9 per cent in FY26: Report

S.Korean drugmaker Celltrion gets USFDA approval for allergic asthma biosimilar

Indian Pharma Market Hits Rs 2.24 Trillion in MAT, With 8.1% Yearly Growth

AstraZeneca Pharma India Gets Approval to Import and Sell Sodium Zirconium Cyclosilicate for Hyperkalaemia Treatment

Celltrion's autoimmune disease treatment gets approval in Europe

Quantum computing, AI to revolutionise drug discovery in India: Ex-ICMR chief

Celltrion gets US FDA approval for new biosimilar for autoimmune disease treatment